OGA and cancer: These studies not only support the idea of targeting aberrant PPIs of OGT/OGA as a novel, potentially more specific anti-cancer strategy, but also highlight that a better understanding of the oncogenic PPIs derived from OGT/OGA at the molecular and systems levels is much needed for such new developments.